# Dual-locked strategy for fluorescence/chemiluminescence dual-modal imaging reprogramming

**Authors:** Qi Wang, Zhao-Yao Song, Zhe Song, Guangji Wang, Le Zhen

PMC · DOI: 10.1039/d5sc09065b · Chemical Science · 2026-03-06

## TL;DR

A new dual-modal imaging probe allows sequential fluorescence and chemiluminescence imaging to detect carbon monoxide in a colitis model.

## Contribution

A novel 'FL-trigger-CL' dual-modal probe with a dual-locked strategy for time-controlled imaging is introduced.

## Key findings

- The FTC-01 probe successfully detected carbon monoxide in cells and a mouse colitis model.
- The dual-locked strategy enables on-demand activation of chemiluminescence after fluorescence detection.
- The probe platform shows compatibility for integrating additional sensing units.

## Abstract

Fluorescence (FL) and chemiluminescence (CL) each offer unique advantages for molecular imaging. FL allows for continuous and real-time tracking of analytes, while CL provides an ultra-high signal-to-background ratio by eliminating the need for exogenous excitation light. Integrating these two modalities for imaging presents significant synergies as well as challenges. However, the rarely reported FL/CL dual-modal probes are typically limited to a “CL–FL” mode, in which both FL and CL signals are activated simultaneously, with the transient CL signals being captured instantly and processed preferentially. In this study, we designed a novel near-infrared FL/CL dual-modal probe that introduces an innovative “FL-trigger-CL” mode for imaging. This approach employs a dual-locked strategy, allowing for flexible and time-controlled triggering of the CRET-based redshift CL signal dependent on fluoride-ion-mediated desilylation, a biocompatible bioorthogonal chemistry. The probe, named FTC-01, was successfully applied to detect carbon monoxide, an endogenous inflammatory biomarker, in both cells and mice with colitis, incorporating FL for primary detection and CL for accurate in-depth detection. This advancement is expected to enhance the application of this dual-modal imaging logic in disease diagnosis and drug candidate screening. Furthermore, our dual-locked probe platform demonstrates excellent compatibility and the potential for expansion, facilitating the integration of a broader range of sensing units and guiding the rational design of dual-modal probes in the future.

A dual-locked probe enables sequential “FL-trigger-CL” imaging, allowing on-demand activation of near-infrared chemiluminescence to validate carbon monoxide elevation in a live colitis model.

## Linked entities

- **Chemicals:** carbon monoxide (PubChem CID 281)
- **Diseases:** colitis (MONDO:0005292)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Diseases:** colitis (MESH:D003092), inflammatory (MESH:D007249)
- **Chemicals:** FTC-01 (-), fluoride (MESH:D005459), carbon monoxide (MESH:D002248)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12991303/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12991303/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12991303/full.md

---
Source: https://tomesphere.com/paper/PMC12991303